Related Experiment Video
Updated: May 31, 2026
09:29
The Bioconjugation and Radiosynthesis of 89Zr-DFO-labeled Antibodies
Published on: February 12, 2015
89Zr radiochemistry for positron emission tomography
Gregory W Severin1, Jonathan W Engle, Todd E Barnhart
1Medical Physics Department, University of Wisconsin-Madison, Madison, WI 53705, USA. gwseverin@wisc.edu
Medicinal Chemistry (Shariqah (United Arab Emirates))
|June 30, 2011
Summary
Zirconium-89 (89Zr) is a key radionuclide for positron emission tomography (PET) imaging. This review details the production and radiolabeling of 89Zr-labeled monoclonal antibodies (mAbs) for advanced PET applications.
Area of Science:
- Nuclear medicine
- Radiochemistry
- Immunology
Background:
- Zirconium-89 (89Zr) is a positron-emitting radionuclide highly suitable for positron emission tomography (PET) imaging.
- Monoclonal antibodies (mAbs) are crucial for targeted therapies and diagnostics.
- Combining 89Zr with mAbs enables highly sensitive in vivo imaging.
Purpose of the Study:
- To review the comprehensive process of producing and utilizing 89Zr-labeled mAbs for PET imaging.
- To cover the journey from radionuclide production to final antibody labeling.
Main Methods:
- Review of cyclotron physics for 89Zr production.
- Discussion of chemical separation techniques for isolating 89Zr from yttrium targets.
- Explanation of 89Zr coordination with desferrioxamine B (DFO) chelate.
- Outline of procedures for conjugating DFO-chelates to mAbs.
Main Results:
- Detailed understanding of 89Zr production methodologies.
- Established protocols for efficient radiolabeling of mAbs with 89Zr.
- Demonstrated feasibility of using 89Zr-labeled mAbs in PET imaging.
Conclusions:
- 89Zr is an optimal choice for developing radiolabeled mAbs for PET imaging.
- The described methods provide a pathway for creating 89Zr-labeled mAbs from production to application.
- This approach facilitates advanced molecular imaging and targeted therapies.
Related Concept Videos
01:29Positron Emission Tomography
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...
01:25Imaging Studies II: Positron Emission Tomography and Scintigraphy
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
Fundamental Principles of PET
01:28Isotopes and Radioisotopes
In the early 1900s, English chemist Frederick Soddy realized that an element could have atoms with different masses that were chemically indistinguishable. These different types are called isotopes — atoms of the same element that differ in mass. Isotopes differ in mass because they have different numbers of neutrons but are chemically identical because they have the same number of protons. Soddy was awarded the Nobel Prize in Chemistry in 1921 for this discovery.
An isotope containing more...
An isotope containing more...